ArticleAdvances in therapy2023

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.

David Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.